Altria Group, Inc. (MO)
Consumer Defensive
- Fundamental
- 4
- Sentiment
- 3
- Technical
- 1
Do Nothing: price 67.95 exceeds the $25 ceiling for this strategy; confirmed earnings on 2026-07-30 and a 5.63% overnight gap add blackout and gap-risk blocks.
Company overview
Altria Group, Inc. manufactures and markets tobacco products in the United States. Its offerings include cigarettes under the Marlboro brand, cigars, pipe tobacco, and moist smokeless tobacco products like Copenhagen and Skoal. The company also sells oral nicotine pouches under the on! brand.
Fundamental
goodAltria demonstrates strong cash generation and profitability, with manageable leverage but faces secular volume decline and regulatory risks.
Fundamental score 4/5: strong cash generation and high profitability, with manageable leverage, offset by secular cigarette volume declines and regulatory risk. FY2025 free cash flow was about $9.07B vs dividends paid about $6.96B; net debt/EBITDA is ~1.96 and interest coverage is ~12.80x. Valuation is reasonable (P/E ~15.77; FCF yield ~7.25%) and discounted-cash-flow estimates imply ~$90.66–$105.53/share (about 21%–41% above $74.92), though the analyst consensus target ($72.33) is slightly below the current quote.
Sentiment
fairMedia coverage is neutral to slightly positive, with low retail engagement and no significant catalysts identified.
Last ~14d media tone is neutral/slightly positive (8 aggregator-tier items), with bullish technical/setup writeups and FDA-proposal chatter offset by institutional selling/trim headlines. The actionable catalyst is Altria’s Q2 results/guidance update on 2026-07-30 (regulator-confirmed via SEC filing referenced upstream), but the 30–90d sentiment delta is indeterminate (baseline news-analyzer timeouts) and Reddit engagement is negligible; no regulator-confirmed investigations surfaced.
Technical
very weakThe stock shows a strong trend above key averages, but recent volatility around earnings limits actionable setups.
MO's short-term structure is broken after a confirmed-earnings gap down: price sits below SMA20/SMA50, EMA9/EMA21, and daily VWAP, while MACD is below its signal and ADX 53.20 confirms the downside impulse. RSI 37.40 and Williams %R -96.71 are oversold, but that currently reads as damage rather than a clean reversal signal; only the SMA200 remains supportive.
You’re looking at 2026-07-30 — about 2 trading days ago.
Subscribers saw this then, and see today’s score, verdict and trade plan now.
More Consumer Defensive
Not financial advice. For informational and educational purposes only.